GENE ONLINE|News &
Opinion
Blog

Ruchi Jhonsa

WRITTEN BY Ruchi Jhonsa

Boehringer Ingelheim’s Ofev Becomes First FDA Approved Treatment for Progressive Interstitial Lung Diseases
2020-03-11
Investigational Gene Therapy for Cystinosis Obtains FDA’s Orphan Drug Designation
2020-03-10
Spotlight: Shionogi’s Big Bet on Tetra Therapeutics
2020-03-07
Roche’s Elecsys GALAD Score that Predicts HCC Occurrence, Bags Breakthrough Designation
2020-03-06
Landmark CRISPR Trial Marks First Ever Gene Editing Inside Human Body
2020-03-05
GIVLAARI to Enter European Market Following EMA Approval
2020-03-04
Keytruda Outcompetes Adcetris in Refractory or Relapsed Hodgkin Lymphoma Study
2020-03-03
Biogen-Sangamo Collaboration Comforts Millions Affected by Neurodegenerative Disorders
2020-02-29
Fight against COVID-19 Strengthens as Gilead Launches Phase III Trial for Remdesivir
2020-02-28
NERLYNX-XELODA Combo Bags FDA Approval for HER2 Positive Breast Cancer Treatment
2020-02-27
EXBLIFEP Surpasses Phase III, Presents Novel Solution for Antibiotic Resistance Crisis in Treating Complicated UTI
2020-02-26
FDA Approval of Cholesterol Lowering Drug, NEXLETOL, A Value-Add to Existing Treatments
2020-02-25
Relief for Patients as Baudax Bio’s Non-Opioid Analgesic Wins FDA Approval
2020-02-23
VistaGen’s Antidepressant Nasal Spray Succeeds Phase 2a Trial
2020-02-22
Padcev Keytruda Combo Garners Breakthrough Therapy Designation for Urothelial Cancer
2020-02-20
1 10 11 12 13
Scroll to Top